DDRE-30. HIGH-THROUGHPUT DRUG SCREENING OF FDA-APPROVED ANTINEOPLASTIC DRUGS FOR THE TREATMENT OF AGGRESSIVE MENINGIOMAS

The management of aggressive meningiomas remains challenging due to limited treatment options besides surgical removal and radiotherapy. High recurrence rates and lack of effective chemotherapies may be reasons for the unfavorable prognosis of these patients. Consequently, there is an urgent need to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Jungwirth, Gerhard, Yu, Tao, Liu, Fang, Warta, Rolf, Unterberg, Andreas, Herold-Mende, Christel
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Drug Discovery, Drug Resistance
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651322/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.275
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares